4//SEC Filing
Audhya Paul K. 4
Accession 0001415889-25-022964
CIK 0001348911other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 7:45 PM ET
Size
9.5 KB
Accession
0001415889-25-022964
Insider Transaction Report
Form 4
Audhya Paul K.
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-08-21−6,250→ 87,500 total→ Common Stock (6,250 underlying) - Exercise/Conversion
Common Stock
2025-08-21+6,250→ 122,783 total - Sale
Common Stock
2025-08-22$13.22/sh−2,942$38,901→ 119,841 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]1/16th of the total restricted stock units subject to the Award shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on May 21, 2025, subject to continued service through each vesting date.
Documents
Issuer
KalVista Pharmaceuticals, Inc.
CIK 0001348911
Entity typeother
Related Parties
1- filerCIK 0001860131
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 7:45 PM ET
- Size
- 9.5 KB